Resilient Biotics Inc.
Resilient Biotics is developing non-antibiotic, microbiome-based therapeutics to combat complex respiratory infections with applications in human and animal health. Resilient utilizes a proprietary discovery platform for product development and has a broad pipeline across multiple species.
Company Location
2 Davis Drive
Durham
NC
27709
County
Region
Company Details
Company type
Year founded
2016
Employment range in NC
US headquarters
North Carolina
Global headquarters
United States
Primary site activity
All company activities
Potential end market(s)
Products under development
The company's lead product, designated "RBX001", is an intranasal, non-antibiotic therapy designed to treat Bovine Respiratory Disease.